Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2−) Breast Cancer-Reference-Cited by-同舟云学术

Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2−) Breast Cancer

Published:2020-08 Issue:4 Volume:20 Page:e403-e409
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Hu Yuanping,Wang Shouman,Ding Nianhua,Li Ningsha,Huang Juan,Xiao Zhi^ORCID

Funder

Youth Teacher Boosting Project of Central South University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Immunity, inflammation, and cancer;Grivennikov;Cell,2010

2. Systemic immunity is required for effective cancer immunotherapy;Spitzer;Cell,2017

3. Immunotherapy for triple-negative breast cancer: existing challenges and exciting prospects;Jia;Drug Resist Updat,2017

4. [Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with gastric cancer];Li;Zhonghua Zhong Liu Za Zhi,2014

5. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a meta-analysis and systematic review;Zheng;Cell Physiol Biochem,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of platelets as a clinical tool in oncology: opportunities and challenges;Cancer Letters;2024-06

2. The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy;Scientific Reports;2024-05-27

3. Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis;British Journal of Surgery;2024-05

4. The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients;Clinical and Translational Oncology;2024-01-08

5. Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index;Turkish Journal of Emergency Medicine;2024-01